Science & Research

The FDA has approved a human trials study by the Yale School of Medicine and CT Pharma investigating the effectiveness of cannabis-based medicines; it’s the first cannabis study on human subjects to be approved by the FDA.

The Centers for Disease Control (CDC) announced a breakthrough on Friday in its investigation into the ongoing vape crisis, singling out vitamin E acetate as the likely culprit behind the spate of hospitalizations and deaths.

A recent study published in the Journal of Psychopharmacology suggests that medical cannabis could significantly reduce PTSD symptoms such as severe depression and suicidal states.

A recent study investigating social responses to the words “cannabis” and “marijuana” found that word choice does not influence the public’s perception of the plant.

A new study by the University of Washington suggests that parents’ cannabis use, past or present, may be linked to their children’s substance abuse tendencies and overall health.

Colorado cannabis company Ebbu has been accused of violating Colorado investment laws by failing to properly disclose investor identities in its early fundraising rounds.

UC San Diego researchers are set to receive $3 million from the state, which will be split between five different CBD research projects.

Australia’s federal government is investing AU$3 million into researching the potential pain and side effect management options for cancer patients.

The USDA is awarding funds to research the transportation of hemp pollen in the wild; the study will use mathematical models and drone technology to monitor hemp’s pollen paths.

Scientists have created a bacteria solution that exudes industrial quantities of psilocybin, the psychedelic compound in “magic mushrooms” that is being studied as a potentially groundbreaking treatment for depression and other mental health afflictions.

Israeli cannabis researcher Dr. Raphael Mechoulam unveiled his latest research into the synthesizing of cannabinoid acids at the CannMed conference last week in Pasadena, California.

GW Pharmaceuticals is partnering up with New York’s Montefiore Medical Center to study CBDV, or cannabidivarin, as a treatment for autism.

Nine universities are receiving federal grants totaling $3 million to study the “potential pain-relieving properties” of minor cannabinoids and cannabis-sourced terpenes.

Yet another study has found that crime rates dropped near legal cannabis dispensaries in the years since cannabis was legalized in Colorado.

The UK’s Imperial College London is partnering with European medical cannabis company EMMAC for a study evaluating cannabis’ entourage effect as a pain relief option.

Researchers at Johns Hopkins University announced last week the formation of what is likely the world’s largest research facility dedicated to psilocybin and psychedelic medicinal research.

The DEA has announced an expansion of medical cannabis research options and a change in policy: hemp cultivators no longer need to register with the agency in light of the crop’s federal legalization.

A new study suggests that cannabis users generally live more enjoyable sex lives, and that cannabis could lead to more and better orgasms, healthier connections with one’s partner, and increased length of sexual activity.

Harvard researchers recently identified a specific cannabis flavonoid that was able to kill tumor cells in 70 percent of mice with pancreatic cancer.

Dr. Sue Sisley of the Scottsdale Research Institute is suing the DEA over hurdles to cannabis research — specifically, that government-sourced cannabis is nothing like the products being used en masse throughout legal states.

Yet another study has come out — this time, based in Colorado — suggesting that adult-use legalization policies do not lead to an uptick in teenage cannabis use.

A new study by the Stanford School of Medicine appears to contradict a commonly cited 2014 study that suggested medical cannabis legalization leads to a reduced rate of opioid overdoses.

A recent study covering 3,023 surveyed California parents found that parents who had used cannabis within the previous year were more likely to discipline their children. Note: this trend was reversed for “lifetime” cannabis users and the data used by researchers was collected in 2009.

Researchers at the University of Guelph in Ontario say they have identified pain-relieving cannabis flavonoids that are “30 times more powerful at reducing inflammation than Aspirin.”